233 related articles for article (PubMed ID: 33567342)
1. Engineered FnCas12a with enhanced activity through directional evolution in human cells.
Liu X; Liu X; Zhou C; Lv J; He X; Liu Y; Xie H; Wang B; Lv X; Tang L; Li M; Liu C; Zhao J; Liu Y; Song Z; Gu F
J Biol Chem; 2021; 296():100394. PubMed ID: 33567342
[TBL] [Abstract][Full Text] [Related]
2. Improving FnCas12a Genome Editing by Exonuclease Fusion.
Wu Y; Yuan Q; Zhu Y; Gao X; Song J; Yin Z
CRISPR J; 2020 Dec; 3(6):503-511. PubMed ID: 33346706
[TBL] [Abstract][Full Text] [Related]
3. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
Murugan K; Seetharam AS; Severin AJ; Sashital DG
J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
[TBL] [Abstract][Full Text] [Related]
5. Development of a Cas12a-Based Genome Editing Tool for Moderate Thermophiles.
Mohanraju P; Mougiakos I; Albers J; Mabuchi M; Fuchs RT; Curcuru JL; van Kranenburg R; Robb GB; van der Oost J
CRISPR J; 2021 Feb; 4(1):82-91. PubMed ID: 33538626
[TBL] [Abstract][Full Text] [Related]
6. Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.
Ratner HK; Weiss DS
J Bacteriol; 2020 May; 202(12):. PubMed ID: 32284320
[TBL] [Abstract][Full Text] [Related]
7. Lb2Cas12a and its engineered variants mediate genome editing in human cells.
Liu X; Lin L; Tang L; Xie H; Gu L; Lv X; Liu C; Zhao J; Deng R; Liu Y; Qu J; Gu F
FASEB J; 2021 Apr; 35(4):e21270. PubMed ID: 33715215
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
Swarts DC; Jinek M
Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
[TBL] [Abstract][Full Text] [Related]
9. Decoupling the bridge helix of Cas12a results in a reduced trimming activity, increased mismatch sensitivity and impaired conformational transitions.
Wörle E; Jakob L; Schmidbauer A; Zinner G; Grohmann D
Nucleic Acids Res; 2021 May; 49(9):5278-5293. PubMed ID: 34009379
[TBL] [Abstract][Full Text] [Related]
10. Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing.
Wei J; Liu J; Wang Z; Yang Y; Tian Y; Wang S; Gao BQ; Gao S; Yang L; Tang J; Wang Y
PLoS Biol; 2024 Jun; 22(6):e3002680. PubMed ID: 38865309
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement
Sansbury BM; Wagner AM; Tarcic G; Barth S; Nitzan E; Goldfus R; Vidne M; Kmiec EB
CRISPR J; 2019 Apr; 2():121-132. PubMed ID: 30998096
[TBL] [Abstract][Full Text] [Related]
12. The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs.
Jacobsen T; Liao C; Beisel CL
FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31004485
[TBL] [Abstract][Full Text] [Related]
13. Multiplexed Genome Engineering with Cas12a.
Weisbach NR; Meijs A; Platt RJ
Methods Mol Biol; 2021; 2312():171-192. PubMed ID: 34228291
[TBL] [Abstract][Full Text] [Related]
14. Indiscriminate ssDNA cleavage activity of CRISPR-Cas12a induces no detectable off-target effects in mouse embryos.
Wei Y; Zhou Y; Liu Y; Ying W; Lv R; Zhao Q; Zhou H; Zuo E; Sun Y; Yang H; Zhou C
Protein Cell; 2021 Sep; 12(9):741-745. PubMed ID: 33797032
[No Abstract] [Full Text] [Related]
15. Multiplexed activation in mammalian cells using a split-intein CRISPR/Cas12a based synthetic transcription factor.
Bryson JW; Auxillos JY; Rosser SJ
Nucleic Acids Res; 2022 Jan; 50(1):549-560. PubMed ID: 34908140
[TBL] [Abstract][Full Text] [Related]
16. Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases.
Tóth E; Varga É; Kulcsár PI; Kocsis-Jutka V; Krausz SL; Nyeste A; Welker Z; Huszár K; Ligeti Z; Tálas A; Welker E
Nucleic Acids Res; 2020 Apr; 48(7):3722-3733. PubMed ID: 32107556
[TBL] [Abstract][Full Text] [Related]
17. Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA.
Shebanova R; Nikitchina N; Shebanov N; Mekler V; Kuznedelov K; Ulashchik E; Vasilev R; Sharko O; Shmanai V; Tarassov I; Severinov K; Entelis N; Mazunin I
Nucleic Acids Res; 2022 Jan; 50(2):1162-1173. PubMed ID: 34951459
[TBL] [Abstract][Full Text] [Related]
18. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA.
Paul B; Chaubet L; Verver DE; Montoya G
Nucleic Acids Res; 2022 May; 50(9):5208-5225. PubMed ID: 34951457
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Cas12a Variants with Relaxed PAM Requirements Expand Genome Editing Compatibility.
Liu Z; Liu H; Huang C; Zhou Q; Luo Y
ACS Synth Biol; 2024 Jun; 13(6):1809-1819. PubMed ID: 38819403
[TBL] [Abstract][Full Text] [Related]
20. Efficient genome editing for Pseudomonas aeruginosa using CRISPR-Cas12a.
Lin Z; Li H; He L; Jing Y; Pistolozzi M; Wang T; Ye Y
Gene; 2021 Jul; 790():145693. PubMed ID: 33961975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
